Donnah Jones

988 total citations
14 papers, 740 citations indexed

About

Donnah Jones is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Donnah Jones has authored 14 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Donnah Jones's work include Prostate Cancer Treatment and Research (6 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Cancer Genomics and Diagnostics (3 papers). Donnah Jones is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Cancer Genomics and Diagnostics (3 papers). Donnah Jones collaborates with scholars based in United States, United Kingdom and Spain. Donnah Jones's co-authors include Christopher J. Logothetis, J R Redman, Jeanne M. Rothberg, Razelle Kurzrock, Fernando Cabanillas, Moshe Talpaz, Paul Mathew, Robert J. Amato, Peter F. Thall and Sun-Jin Kim and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Donnah Jones

14 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Donnah Jones United States	12	280	221	177	166	112	14	740
Shunji Miki Japan	9	231 0.8×	91 0.4×	179 1.0×	189 1.1×	60 0.5×	15	651
Masafumi Takimoto Japan	13	402 1.4×	171 0.8×	120 0.7×	213 1.3×	131 1.2×	40	815
Denise McLain United States	14	288 1.0×	223 1.0×	157 0.9×	240 1.4×	112 1.0×	32	690
Fadi Farhat Lebanon	17	196 0.7×	234 1.1×	65 0.4×	188 1.1×	135 1.2×	55	684
Jan Kornafel Poland	16	411 1.5×	90 0.4×	182 1.0×	246 1.5×	103 0.9×	73	832
Kwang‐Sun Suh South Korea	15	183 0.7×	105 0.5×	130 0.7×	235 1.4×	105 0.9×	55	802
Ching-Liang Ho Taiwan	13	475 1.7×	451 2.0×	140 0.8×	251 1.5×	116 1.0×	27	923
Takeshi Nagao Japan	16	241 0.9×	166 0.8×	139 0.8×	184 1.1×	419 3.7×	64	1.3k
Ugochukwu C. Nzeako United States	14	189 0.7×	100 0.5×	116 0.7×	144 0.9×	195 1.7×	19	1.1k
Lai‐Fa Sheu Taiwan	21	330 1.2×	118 0.5×	136 0.8×	439 2.6×	135 1.2×	44	1.1k

Countries citing papers authored by Donnah Jones

Since Specialization

Citations

This map shows the geographic impact of Donnah Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donnah Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donnah Jones more than expected).

Fields of papers citing papers by Donnah Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donnah Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donnah Jones. The network helps show where Donnah Jones may publish in the future.

Co-authorship network of co-authors of Donnah Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Donnah Jones. A scholar is included among the top collaborators of Donnah Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donnah Jones. Donnah Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Aparicio, Ana M., Andrea Harzstark, Emile N.J.T. van Lin, et al.. (2011). Characterization of the anaplastic prostate carcinomas: A prospective two-stage phase II trial of frontline carboplatin and docetaxel (CD) and salvage etoposide and cisplatin (EP).. Journal of Clinical Oncology. 29(15_suppl). 4666–4666. 3 indexed citations

Tu, Shi‐Ming, Paul Mathew, Franklin C. Wong, et al.. (2009). Phase I Study of Concurrent Weekly Docetaxel and Repeated Samarium-153 Lexidronam in Patients With Castration-Resistant Metastatic Prostate Cancer. Journal of Clinical Oncology. 27(20). 3319–3324. 37 indexed citations

Mathew, Paul, Peter F. Thall, Corazon D. Bucana, et al.. (2007). Platelet-Derived Growth Factor Receptor Inhibition and Chemotherapy for Castration-Resistant Prostate Cancer with Bone Metastases. Clinical Cancer Research. 13(19). 5816–5824. 68 indexed citations

Panopoulos, Athanasia D., Ling Zhang, Jonathan W. Snow, et al.. (2006). STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils. Blood. 108(12). 3682–3690. 154 indexed citations

Mathew, Paul, Peter F. Thall, Donnah Jones, et al.. (2004). Platelet-Derived Growth Factor Receptor Inhibitor Imatinib Mesylate and Docetaxel: A Modular Phase I Trial in Androgen-Independent Prostate Cancer. Journal of Clinical Oncology. 22(16). 3323–3329. 101 indexed citations

Millikan, Randall E., Peter F. Thall, Sang Joon Lee, et al.. (2003). Randomized, Multicenter, Phase II Trial of Two Multicomponent Regimens in Androgen-Independent Prostate Cancer. Journal of Clinical Oncology. 21(5). 878–883. 32 indexed citations

Saad, Everardo D., Eric H. Kraut, Paulo M. Hoff, et al.. (2002). Phase II Study of Dolastatin-10 as First-Line Treatment for Advanced Colorectal Cancer. American Journal of Clinical Oncology. 25(5). 451–453. 48 indexed citations

Pagliaro, Lance C., Danai Daliani, Robert J. Amato, et al.. (2000). A Phase II trial of bryostatin-1 for patients with metastatic renal cell carcinoma. Cancer. 89(3). 615–618. 42 indexed citations

Corral, David A., Avishay Sella, Curtis A. Pettaway, et al.. (1998). COMBINATION CHEMOTHERAPY FOR METASTATIC OR LOCALLY ADVANCED GENITOURINARY SQUAMOUS CELL CARCINOMA: A PHASE II STUDY OF METHOTREXATE, CISPLATIN AND BLEOMYCIN. The Journal of Urology. 160(5). 1770–1774. 60 indexed citations

10.

Tu, Shi‐Ming, Ebrahim S. Delpassand, Donnah Jones, et al.. (1996). Strontium-89 combined with doxorubicin in the treatment of patients with androgen-independent prostate cancer. Urologic Oncology Seminars and Original Investigations. 2(6). 191–197. 20 indexed citations

11.

Kurzrock, Razelle, J R Redman, Fernando Cabanillas, et al.. (1993). Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.. PubMed. 53(9). 2118–22. 135 indexed citations

12.

Ackrill, P., et al.. (1988). Intraperitoneal teicoplanin in the treatment of peritonitis associated with continious ambulatory peritoneal dialysis. Journal of Antimicrobial Chemotherapy. 21(suppl A). 133–139. 20 indexed citations

13.

Jones, Donnah, et al.. (1984). Observations on the toxicity of the combination of gentamicin and mezlocillin in the treatment of patients with acute leukaemia. Journal of Antimicrobial Chemotherapy. 14(4). 411–421. 2 indexed citations

14.

Gallagher, Peggy A., et al.. (1981). Acute pancreatitis associated with campylobacter infection. British journal of surgery. 68(6). 383–383. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact